EUVIMEDEUVIMED entdecken
Crossref

Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV

Alice Varghese, Nancy Pandita, Jay Savai

Journal of Pharmaceutical Negative Results · 2013

DOI: 10.4103/0976-9234.116766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Negative Results, 2013. Verfasst von Alice Varghese und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Withania somnifera is widely employed as a rejuvenator and expected topromote physical health and increase longevity. The aim of the present research workwas to evaluate Cytochrome P450 3A (CYP3A) interaction of Withania somnifera.Materials and Methods: In vitro CYP3A interaction of methanolic extract ofWithania somnifera (WS) and its principal phytoconstituents: Withaferin–A (WA),Withanolide–A (WL‑A) and Withanoside–IV (WS‑IV) were investigated in ratand human liver microsomes. In vivo CYP3A interaction potential was investigatedby administering methanolic extract of WS orally at a dose of 500 mg/kg in femaleWistar rats. Sildenafil citrate was used to index the activity of CYP3A.

Results

IC50values of methanolic extract of Withania somnifera, WA, WL‑A, WS‑IV were foundto be 200 µg/ml, >20 µM, >64 µM and >64 µM for CYP3A both in rats and humans,respectively. When sildenafil citrate was orally co‑administered with methanolicextract of WS and compared with orally administered sildenafil citrate alone, thearea under plasma concentration time (AUC) curve and Cmax did not significantlydiffer as compared to the group which received rifampicin orally (positive control).

Conclusions

Results suggested that methanolic extract of WS, WA, WL‑A, WS‑IVshowed no in vitro CYP3A inhibition in rats and humans. Methanolic extract of WSdid not significantly alter the pharmacokinetics of sildenafil citrate in rats; indicatingits safety when co‑administered with other drugs that are substrates of CYP3A. Thusthe results indicate the lesser likelihood of drug herb interactions when concomitantlyadministered with CYP3A substrates.

Zitieren

APA

Varghese, A., Pandita, N., & Savai, J. (2013). Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV. Journal of Pharmaceutical Negative Results. https://doi.org/10.4103/0976-9234.116766

Vancouver

Varghese A, Pandita N, Savai J. Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV. Journal of Pharmaceutical Negative Results. 2013. doi:10.4103/0976-9234.116766

BibTeX
@article{Varghese2013,
  author = {Varghese, Alice and Pandita, Nancy and Savai, Jay},
  title = {Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV},
  journal = {Journal of Pharmaceutical Negative Results},
  year = {2013},
  doi = {10.4103/0976-9234.116766}
}
Kostenlos starten →